The authors found that moesin acts as a key promotor of chemoradiotherapy resistance in glioma stem cells, enhancing their proliferation and stemness maintenance.
[Advanced Science]
Home Newsletters Cancer Stem Cell News GNE-317 Reverses MSN-Mediated Proneural-to-Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via...
